李 偉華

Medicine & Life Sciences

1. Neoplasms 100%
2. Neoplastic Stem Cells 75%
3. Hepatocellular Carcinoma 64%
4. Neoplasm Metastasis 58%
5. Glioma 43%
6. Down-Regulation 41%
7. Cell Line 37%
8. 4-acetylantroquinonol B 36%
9. Apoptosis 36%
10. pterostilbene 35%
11. Adenocarcinoma 35%
12. Nasopharyngeal Carcinoma 35%
13. Cisplatin 34%
14. ovatodiolide 34%
15. Glioblastoma 31%
16. Immunoglobulin A 31%
17. Carcinoma 30%
18. Antigen-Antibody Complex 28%
19. Proteinuria 28%
20. Breast Neoplasms 27%
21. Therapeutics 26%
22. Phenotype 26%
23. Tissue Array Analysis 25%
24. Brain 25%
25. MicroRNAs 25%
26. Meningioma 25%
27. Human Herpesvirus 4 24%
28. Squamous Cell Carcinoma 22%
29. Hemangiopericytoma 22%
30. Nude Mice 22%
31. Myeloid-Derived Suppressor Cells 21%
32. Colorectal Neoplasms 21%
33. Stem Cells 21%
34. Growth 20%
35. Carcinogenesis 20%
36. Drug Therapy 20%
37. Catenins 19%
38. Antrodia 19%
39. signal peptide peptidase 19%
40. Epithelial-Mesenchymal Transition 19%
41. Sorafenib 19%
42. Stomach 18%
43. In Vitro Techniques 18%
44. matriptase 18%
45. osthol 17%
46. Metalloproteases 17%
47. Kidney 17%
48. Adenocarcinoma of Lung 17%
49. Proteins 16%